Przejdź do zawartości
Merck
Wszystkie zdjęcia(1)

Key Documents

H-003

Supelco

Hydrocodone solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych
Wszystkie zdjęcia(1)

About This Item

Wzór empiryczny (zapis Hilla):
C18H21NO3
Numer CAS:
125-29-1
Masa cząsteczkowa:
299.36
Kod UNSPSC:
41116107
NACRES:
NA.24

klasa czystości

certified reference material

Poziom jakości

300

Postać

liquid

Właściwości

Snap-N-Spike®/Snap-N-Shoot®

opakowanie

ampule of 1 mL

producent / nazwa handlowa

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)

stężenie

1.0 mg/mL in methanol

metody

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

Zastosowanie

forensics and toxicology

format

single component solution

temp. przechowywania

−20°C

InChI

1S/C18H21NO3.C4H6O6.H2O/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19;5-1(3(7)8)2(6)4(9)10;/h3,6,11-12,17H,4-5,7-9H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10);1H2/t11-,12+,17-,18-;1-,2-;/m01./s1

Klucz InChI

ZICRJLQTAUVSDU-NSJZFRMTSA-N

Szukasz podobnych produktów? Odwiedź Przewodnik dotyczący porównywania produktów

Powiązane kategorie

Opis ogólny

Hydrocodone is a semi-synthetic opioid derived from codeine or thebaine, two naturally-occurring opiates. The drug, also known as dihydrocodeinone, is used as an analgesic to treat pain and as an antitussive for coughing or related conditions. This Certified Spiking Solution® is suitable as a starting material for calibrators or controls in GC/MS or LC/MS testing applications from pharmaceutical research and pain prescription monitoring to clinical toxicology and forensic analysis.

Zastosowanie


  • Hydrocodone Bitartrate ER: A Review in Chronic Pain.: This comprehensive review evaluates the extended-release formulation of hydrocodone, focusing on its pharmacological properties, therapeutic efficacy, and clinical applications in managing chronic pain, which underscores its significance in long-term pain management strategies (Dhillon S, 2016).

Polecane produkty

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

Informacje prawne

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
This page may contain text that has been machine translated.

produkt powiązany

Numer produktu
Opis
Cennik

H-005

Hydrocodone-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

P-071

Pain Management Multi-component Opiate Mixture-13 solution, 100 μg/mL each component (10 μg/mL Fentanyl), ampule of 1.0 mL, certified reference material, Cerilliant®

O-020

Opiate Multi-component Mixture-5 solution, 250 μg/mL each component in methanol, ampule of 1.0 mL, certified reference material, Cerilliant®

H-008

Hydrocodone-D3 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-047

Hydrocodone-D6 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-048

Hydrocodone-D6 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

N-053

Norhydrocodone hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-054

Norhydrocodone-d3 hydrochloride, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

H-003S

Hydrocodone solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

Hasło ostrzegawcze

Danger

Zwroty wskazujące rodzaj zagrożenia

H225,H301 + H311 + H331,H370

Klasyfikacja zagrożeń

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Organy docelowe

Eyes

Kod klasy składowania

3 - Flammable liquids

Klasa zagrożenia wodnego (WGK)

WGK 2

Temperatura zapłonu (°F)

49.5 °F - closed cup

Temperatura zapłonu (°C)

9.7 °C - closed cup

Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Klienci oglądali również te produkty

Slide 1 of 6

1 of 6

Meperidine solution 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

M-035

Meperidine solution

Temazepam solution 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

T-907

Temazepam solution

Buprenorphine solution 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

B-902

Buprenorphine solution

Fentanyl solution 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

F-002

Fentanyl solution

Fentanyl solution 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

F-013

Fentanyl solution

Morphine solution 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

M-005

Morphine solution

FDA committee: More restrictions needed on hydrocodone combination products.
Bridget M Kuehn
JAMA, 309(9), 862-862 (2013-03-07)
Rachel Wightman et al.
Journal of medical toxicology : official journal of the American College of Medical Toxicology, 8(4), 335-340 (2012-09-21)
Nonmedical use of prescription opioid analgesics is associated with epidemic levels of morbidity and mortality. There are several factors that affect the abuse liability of the various opioids, including likability or the pleasurable subjective effects. Due to rising public health
David Alexander et al.
The Laryngoscope, 122(11), 2378-2381 (2012-09-12)
Two million new users will abuse prescription narcotics this year, most commonly hydrocodone. The most commonly prescribed form is hydrocodone-acetaminophen (HA). Many individuals crush the tablets and snort the product to take advantage of the rapid transmucosal delivery of narcotics.
Justin D Khetani et al.
Paediatric drugs, 14(6), 411-415 (2012-09-28)
Recent case reports have alerted the medical community of fatality in children receiving codeine after tonsillectomy and/or adenoidectomy for obstructive sleep apnea syndrome. The objective of this study was to compare the rates of oxygen desaturation before and after adenotonsillectomy
Recent issues regarding controlled substances.
Dave Helgeland
South Dakota medicine : the journal of the South Dakota State Medical Association, 66(3), 105-105 (2013-04-03)
Wyświetl wszystkie powiązane dokumenty

Produkty

Benefits of Ascentis Express Phenyl-Hexyl over Biphenyl for the Separation of Pain Management Opiates

Although both biphenyl and phenyl-hexyl phases can resolve these compounds, the former exhibits excellent peak shape and substantially less silanol-derived ion exchange activity.

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej